ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, supplying promising advancements across many medical and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA provides a safer, additional reliable substitute for therapeutic use, spec